UniprotID	Q63HN8-5
Accession	Q63HN8;C9JCP4;D6RI12;F8WKS1;Q658P6;Q69YK7;Q6MZR1;Q8IWF4;Q8IZX1;Q8IZX2;Q8N406;Q8TEU0;Q9H6C9;Q9H6H9;Q9H6P3;Q9H8A9;Q9HCF4;Q9HCL8
EntryName	RN213_HUMAN
ProteinName	E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (E3 ubiquitin-lipopolysaccharide ligase RNF213) (EC 2.3.2.-) (Mysterin) (RING finger protein 213)
GeneName	RNF213 ALO17 C17orf27 KIAA1554 KIAA1618 MYSTR
Length	1063
Function	Atypical E3 ubiquitin ligase that can catalyze ubiquitination of both proteins and lipids, and which is involved in various processes, such as lipid metabolism, angiogenesis and cell-autonomous immunity (PubMed:21799892, PubMed:26126547, PubMed:26278786, PubMed:26766444, PubMed:30705059, PubMed:32139119, PubMed:34012115). Acts as a key immune sensor by catalyzing ubiquitination of the lipid A moiety of bacterial lipopolysaccharide (LPS) via its RZ-type zinc-finger: restricts the proliferation of cytosolic bacteria, such as Salmonella, by generating the bacterial ubiquitin coat through the ubiquitination of LPS (PubMed:34012115). Also acts indirectly by mediating the recruitment of the LUBAC complex, which conjugates linear polyubiquitin chains (PubMed:34012115). Ubiquitination of LPS triggers cell-autonomous immunity, such as antibacterial autophagy, leading to degradation of the microbial invader (PubMed:34012115). Involved in lipid metabolism by regulating fat storage and lipid droplet formation; act by inhibiting the lipolytic process (PubMed:30705059). Also regulates lipotoxicity by inhibiting desaturation of fatty acids (PubMed:30846318). Also acts as an E3 ubiquitin-protein ligase via its RING-type zinc finger: mediates 'Lys-63'-linked ubiquitination of target proteins (PubMed:32139119, PubMed:33842849). Involved in the non-canonical Wnt signaling pathway in vascular development: acts by mediating ubiquitination and degradation of FLNA and NFATC2 downstream of RSPO3, leading to inhibit the non-canonical Wnt signaling pathway and promoting vessel regression (PubMed:26766444). Also has ATPase activity; ATPase activity is required for ubiquitination of LPS (PubMed:34012115).
Subcellular Location	Cytoplasm; Cytosol; Lipid droplet
Disorder	
ExposeBuried	
SurfaceAccessbility	
SecondStructure	
Hydropathy	
Polar	
Charge	
UniprotNLSRegion	
UniprotNESRegion	
SeqNLSRegion	
SeqNLSPMID	
nlsdbnes_region	
nlsdbnls_region	
validnes_region	
nesbase_region	
Sequence	MECPSCQHVSKEETPKFCSQCGERLPPAAPIADSENNNSTMASASEGEMECGQELKEEGGPCLFPGSDSWQENPEEPCSKASWTVQESKKKKRKKKKKGNKSASSELASLPLSPASPCHLTLLSNPWPQDTALPHSQAQQSGPTGQPSQPPGTATTPLEGDGLSAPTEVGDSPLQAQALGEAGVATGSEAQSSPQFQDHTEGEDQDASIPSGGRGLSQEGTGPPTSAGEGHSRTEDAAQELLLPESKGGSSEPGTELQTTEQQAGASASMAVDAVAEPANAVKGAGKEMKEKTQRMKQPPATTPPFKTHCQEAETKTKDEMAAAEEKVGKNEQGEPEDLKKPEGKNRSAAAVKNEKEQKNQEADVQEVKASTLSPGGGVTVFFHAIISLHFPFNPDLHKVFIRGGEEFGESKWDSNICELHYTRDLGHDRVLVEGIVCISKKHLDKYIPYKYVIYNGESFEYEFIYKHQQKKGEYVNRCLFIKSSLLGSGDWHQYYDIVYMKPHGRLQKVMNHITDGPRKDLVKGKQIAAALMLDSTFSILQTWDTINLNSFFTQFEQFCFVLQQPMIYEGQAQLWTDLQYREKEVKRYLWQHLKKHVVPLPDGKSTDFLPVDCPVRSKLKTGLIVLFVVEKIELLLEGSLDWLCHLLTSDASSPDEFHRDLSHILGIPQSWRLYLVNLCQRCMDTRTYTWLGALPVLHCCMELAPRHKDAWRQPEDTWAALEGLSFSPFREQMLDTSSLLQFMREKQHLLSIDEPLFRSWFSLLPLSHLVMYMENFIEHLGRFPAHILDCLSGIYYRLPGLEQVLNTQDVQDVQNVQNILEMLLRLLDTYRDKIPEEALSPSYLTVCLKLHEAICSSTKLLKFYELPALSAEIVCRMIRLLSLVDSAGQRDETGNNSVQTVFQGTLAATKRWLREVFTKNMLTSSGASFTYVKEIEVWRRLVEIQFPAEHGWKESLLGDMEWRLTKEEPLSQITAYCNSCWDTKGLEDSVAKTFEKCIIEAVSSACQVNNLSSWETDSGSQLCSAMTQLRAMKHPLGLSSSANSEIGKWAPSSLAKGNGAEI
PTM	Acetylation:287,353,1490,1501,2431,2877,4254,4264,4349,4354;Methylation:56,307,524,605,632,850,1049,1111,1151,1162,1294,1313,1322,1344,1425,1442,1478,1591,1694,1733,2016,2021,2129,2248,2296,2447,2699,2749,2854,2961,3019,3047,3202,3311,3360,3404,3559,3580,3737,3785,3876,3887,3957,4057,4136,4140,4158,4185,4254,4312,4547,4606,4622,4629,4796,4853,4955,4968,5065,5140;Phosphorylation:14,34,39,40,43,45,67,69,82,88,217,221,225,226,232,302,303,447,515,831,883,887,929,931,932,1066,1159,1245,1258,1264,1411,1422,1528,1596,1730,1737,1745,1785,1973,1975,1999,2001,2104,2105,2108,2110,2111,2266,2269,2270,2273,2397,2434,2455,2456,2462,2531,2558,2774,2837,2839,2904,2934,2956,2957,2958,2970,3096,3357,3369,3397,3520,3577,3775,4116,4181,4187,4189,4225,4670,4719,4751,4896,4962,4972,5110,5157,5161;SUMOylation:863,4716;Ubiquitylation:595,605,911,967,1058,1069,1079,1223,1248,1404,1694,1971,2003,2016,2021,2136,2367,2447,2529,2779,2915,2968,2990,3028,3159,3255,3591,3738,3876,3966,3982,4206,4256,4312,4335,4349,4408,4547,4671,4716,4796,4815,4968,4974,5095,5106,5142
